|3.32|| +0.07 / +2.15%|
ADMA Biologics, Inc. is a biopharmaceutical company, which develops, manufactures and intends to commercialize in human plasma and plasma-derived therapeutics. It operates through the Plasma Collection Center and Research and Development segments. The Plasma Collection Center segment comprises of operations in Georgia. The Research and Development segment involves plasma development operations in New Jersey. The company's targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA Biologics was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.
|Adam S. Grossman||President, Chief Executive Officer & Director|
|Brian Lenz||Chief Financial & Principal Accounting Officer, VP|
|James Mond||Executive VP, Chief Scientific & Medical Officer|
|Theresa Gwaltney||Senior Director-Supply Chain Operations|
|James Hauert||Senior Vice President-Commercialization & Strategy|